Malignant hypercalcemia in pregnancy: Effect of pamidronate on uterine contractions

Obstetrics and Gynecology

Volumn 108, Issue 3 II, 2006, Pages 789-791

  Culbert, Emily C ^a   Schfirin, Barry S ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; DOXORUBICIN; PACLITAXEL; PAMIDRONIC ACID;

ADULT; ANAMNESIS; ARTICLE; BREAST CANCER; CALCIUM BLOOD LEVEL; CANCER CHEMOTHERAPY; CASE REPORT; DRUG EFFECT; FEMALE; GESTATIONAL AGE; HUMAN; HYPERCALCEMIA; KIDNEY FUNCTION; LABORATORY TEST; METASTASIS; PREGNANCY; PRIORITY JOURNAL; TREATMENT FAILURE; UTERUS CONTRACTION;

ADULT; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; BREAST NEOPLASMS; BREECH PRESENTATION; CESAREAN SECTION; DIPHOSPHONATES; FATAL OUTCOME; FEMALE; GESTATIONAL AGE; HUMANS; HYPERCALCEMIA; INFANT, NEWBORN; INFANT, PREMATURE; OBSTETRIC LABOR, PREMATURE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; UTERINE CONTRACTION;

EID: 33748105239     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000209183.39581.e9     Document Type: Article

References (8)

1. Barthelmes L, Davidson LA, Gaffney C, Gateley CA. Pregnancy and breast cancer. BMJ 2005;330:1375-8.
2. Mestman JH. Parathyroid disorders of pregnancy. Semin Perinatol 1998;22:485-96.
3. Cherry TA, Kauffman RP, Myles TD. Primary hyperparathyroidism, hypercalcemic crisis and subsequent seizures occurring during pregnancy: a case report. J Matern Fetal Neonatal Med 2002;12:349-52.
4. Munns CF, Rauch F, Ward L, Glorieux FH. Maternal and fetal outcome after long-term pamidronate treatment before conception: a report of two cases. J Bone Miner Res 2004;19:1742-5.
5. Graepel P, Bentley P, Fritz H, Miyamoto M, Slater SR. Reproduction toxicity studies with pamidronate. Arzneimittelforschung 1992;42:654-67.
6. Reinholz GG, Getz B, Sanders ES, Karpeisky MY, Padyukova N, Mikhailov SN, et al. Distinct mechanisms of bisphosphonate action between osteoblasts and breast cancer cells: identity of a potent new bisphosphonate analogue. Breast Cancer Res Treat 2002;71:257-68.
7. Dunlop DJ, Soukop M, McEwan HP. Antenatal administration of aminopropylidene diphosphonate. Ann Rheum Dis 1990;49:955.
8. Illidge TM, Hussey M, Godden CW. Malignant hypercalcaemia in pregnancy and antenatal administration of intravenous pamidronate. Clin Oncol (R Coll Radiol) 1996;8:257-8.